Analysts Differ in Opinion on Jakafi Drug Maker Incyte (INCY) [Yahoo! Finance]
Incyte Corporation (INCY)
Last incyte corporation earnings: 2/13 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
incyte.com/ir/investor-overview.aspx
Company Research
Source: Yahoo! Finance
Tazeen Ahmad assigned a Buy rating to Incyte and set a $118 price target. This bullish ratings action stands in contrast to Wells Fargo's downgrade of Incyte Corp (NASDAQ:INCY) to Equal Weight from Overweight on January 20. According to Wells Fargo, which also lowered the stock's price target to $107 from $116, the downgrade reflects the company's current valuation and limited near-term growth drivers. Earlier this month, two analysts offered contrasting views on Incyte Corp (NASDAQ:INCY), particularly regarding its myelofibrosis medication Jakafi. On January 6, TD Cowen analyst Marc Frahm affirmed his Buy rating on the stock, citing the company's transition beyond relying on Jakafi. However, on January 14, William Blair analyst Matt Phipps gave a hold rating on Incyte Corp (NASDAQ:INCY), noting that while the company seeks growth beyond Jakafi, it remains to be seen whether its next wave of products can offset the anticipated peak and decline of Jakafi revenues toward the end of th
Show less
Read more
Impact Snapshot
Event Time:
INCY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
INCY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
INCY alerts
High impacting Incyte Corporation news events
Weekly update
A roundup of the hottest topics
INCY
News
- Incyte (INCY) Q4 Earnings: What To Expect [Yahoo! Finance]Yahoo! Finance
- Incyte (NASDAQ:INCY) had its "overweight" rating reaffirmed by analysts at Piper Sandler.MarketBeat
- TD Cowen Keeps Buy Rating on Incyte (INCY), Cites Roadmap to Triple Non-Jakafi Revenue by 2029 [Yahoo! Finance]Yahoo! Finance
- Incyte (NASDAQ:INCY) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $135.00 price target on the stock.MarketBeat
- Incyte (NASDAQ:INCY) had its "overweight" rating reaffirmed by analysts at Barclays PLC.MarketBeat
INCY
Earnings
- 10/28/25 - Beat
INCY
Sec Filings
- 2/4/26 - Form 4
- 2/4/26 - Form 4
- 1/21/26 - Form 4
- INCY's page on the SEC website